Tuesday, July 14, 2026

HomeHealth NewsEngineers develop AI tool to design peptides that turn signals on or...

Engineers develop AI tool to design peptides that turn signals on or off

- Advertisement -

In computational analyses, TD3B generated agonists and antagonists that would contact the key activation and deactivation sites used by known GLP-1 drugs, without ever being told which sites to target. Credit: Aastha Pal

To develop new and better peptides, the short amino acid strings behind medicines like GLP-1 drugs, researchers have used AI to generate candidates and to predict their…

Click here to view the original article.

- Advertisment -
- Advertisement -

Recently Viewed